Soligenix
SNGX0.36192.53% ( -0.0094 )
Soligenix (SNGX)
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United State...
- Open
- 0.3713
- High
- 0.3799
- Low
- 0.3574
- Prev. Close
- 0.3713
- Volume
- 249.41K
- Turnover
- 90.59K
- Avg Price
- 0.3632
- Bid/Ask Ratio
- --
- Amplitude
- 6.06%
- 52wk High
- 6.2300
- Volume Ratio
- 0.81
- Turnover Ratio
- 1.69%
Soligenix Analyst Rating
View MoreForecast & Rating
May 14, 2026Price forecast
$1.75383.56%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jul 21 at 03:27 PM
Soligenix announces annual shareholder meeting
- PUBT · Jun 26 at 03:07 PM
Soligenix increases at-the-market offering by additional $2.5 million
- StockTitan · Jun 25 at 10:00 PM
From Vaccines to Therapeutics; How Biotech Is Addressing the Ebola Outbreak | AEMD Stock News
- StockTitan · Jun 7 at 10:30 PM
Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine | SNGX Stock News
- benzinga_article · Jun 3 at 12:06 PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
- nasdaq · Jun 3 at 08:20 AM
Pre-Market Movers: PMI, CNTB, RNAZ Chart The Course
